Table 3.
Complementation group | No neurological involvement | Xeroderma pigmentosum neurological involvementa | Non-XP neurological involvement | Total | ||
---|---|---|---|---|---|---|
Mild | Moderate | Severe | ||||
A | 2 | 2 | 1 | 3 | 1 | 9 |
B | 0 | 0 | 0 | 0 | 1 | 1 |
C | 36 | 0 | 0 | 0 | 2 | 38 |
D | 5 | 4 | 2 | 5 | 1 | 17 |
E | 2 | 0 | 0 | 0 | 0 | 2 |
G | 1 | 0 | 0 | 0 | 1 | 2 |
XP-variant | 5 | 0 | 0 | 0 | 0 | 5 |
Unknown | 4 | 0 | 0 | 0 | 1 | 5 |
Total | 55 | 6 | 3 | 8 | 7 | 79 |
a Modified from Nishigori et al. (1994) (Fig. 2).
XP = xeroderma pigmentosum.